Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided maxillary nerve block for pain after orbital fracture surgery
IRCT20240517061826N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropivacaine and dexamethasone in Orbital fracture (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Perioperative opioid consumption and Pain after orbital fracture surgery. Started Jun 2025; status: completed.
02
Drugs
ropivacainedexamethasone
03
Conditions
Orbital fracture
Beyond the preview
Go deeper on IRCT20240517061826N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240517061826N1.